ATE532498T1 - Zusammensetzung mit ginsenosid f1 und egcg zur prävention von hautschäden - Google Patents
Zusammensetzung mit ginsenosid f1 und egcg zur prävention von hautschädenInfo
- Publication number
- ATE532498T1 ATE532498T1 AT04735693T AT04735693T ATE532498T1 AT E532498 T1 ATE532498 T1 AT E532498T1 AT 04735693 T AT04735693 T AT 04735693T AT 04735693 T AT04735693 T AT 04735693T AT E532498 T1 ATE532498 T1 AT E532498T1
- Authority
- AT
- Austria
- Prior art keywords
- egcg
- ginsenoside
- composition
- skin damage
- prevent skin
- Prior art date
Links
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 title abstract 3
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 title abstract 3
- BGHNZAWRRWLKPO-UHFFFAOYSA-N Ginsenoside F1 Natural products CC(=C)CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C BGHNZAWRRWLKPO-UHFFFAOYSA-N 0.000 title abstract 3
- XNGXWSFSJIQMNC-FIYORUNESA-N ginsenoside F1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@H](O)[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XNGXWSFSJIQMNC-FIYORUNESA-N 0.000 title abstract 3
- 230000037380 skin damage Effects 0.000 title 1
- 230000006907 apoptotic process Effects 0.000 abstract 2
- 210000001339 epidermal cell Anatomy 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000009044 synergistic interaction Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020040020800A KR100868905B1 (ko) | 2004-03-26 | 2004-03-26 | 진세노사이드 ｆ1과 ｅｇｃｇ을 함유한 자외선 조사로유도되는 피부손상 방지용 조성물 |
| PCT/KR2004/001303 WO2005092280A1 (en) | 2004-03-26 | 2004-06-01 | Composition containing ginsenoside f1 and egcg for preventing skin damage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE532498T1 true ATE532498T1 (de) | 2011-11-15 |
Family
ID=35055962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04735693T ATE532498T1 (de) | 2004-03-26 | 2004-06-01 | Zusammensetzung mit ginsenosid f1 und egcg zur prävention von hautschäden |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20080280838A1 (de) |
| EP (1) | EP1727512B1 (de) |
| JP (1) | JP4814870B2 (de) |
| KR (1) | KR100868905B1 (de) |
| CN (1) | CN100467010C (de) |
| AT (1) | ATE532498T1 (de) |
| WO (1) | WO2005092280A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101326690B1 (ko) * | 2007-10-31 | 2013-11-08 | (주)아모레퍼시픽 | 고려 인삼 유래의 멜라닌 합성 저해 물질을 함유하는 미백화장료 조성물 |
| KR101909533B1 (ko) * | 2012-02-21 | 2018-10-19 | (주)아모레퍼시픽 | 진세노사이드 ｆ１을 함유하는 피부 외용제 조성물 |
| KR20170047007A (ko) * | 2015-10-22 | 2017-05-04 | (주)아모레퍼시픽 | 효소적 방법에 의하여 인삼의 사포닌으로부터 진세노사이드 F2, 컴파운드 Mc 및 컴파운드 O를 선택적으로 제조하는 방법 |
| CN106176455B (zh) * | 2016-08-26 | 2019-04-12 | 江苏天晟药业股份有限公司 | 一种美白抗衰老护肤品及其制备方法 |
| CN106334071A (zh) * | 2016-10-14 | 2017-01-18 | 苏州药基美研医药科技有限公司 | 一种基于egcg和芦荟提取物的外用制剂 |
| KR20210087893A (ko) * | 2018-06-04 | 2021-07-13 | 케미스트리알엑스. | 모발 성장 촉진을 위한 국소 조성물 |
| KR101939112B1 (ko) * | 2018-08-29 | 2019-01-17 | (주)아모레퍼시픽 | 진세노사이드 ｆ１을 함유하는 피부 외용제 조성물 |
| CN117503810B (zh) * | 2023-11-08 | 2024-05-24 | 上海迈向胜利健康技术有限公司 | 一种免疫调节组合物及其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6001992A (en) * | 1999-01-07 | 1999-12-14 | Isis Pharmaceuticals Inc. | Antisense modulation of novel anti-apoptotic bcl-2-related proteins |
| JP3661707B2 (ja) * | 1993-10-28 | 2005-06-22 | 三省製薬株式会社 | 皮膚外用剤 |
| CN1104621A (zh) * | 1993-11-18 | 1995-07-05 | 安徽省黄山市东方茶多酚厂 | 茶多酚提取新工艺 |
| FR2737971B1 (fr) * | 1995-08-25 | 1997-11-14 | Lvmh Rech | Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee |
| EP1003859A1 (de) * | 1997-07-25 | 2000-05-31 | Neurovex Limited | Verwendung von transkriptionsfaktor brn-3a |
| AU2000258901A1 (en) * | 2000-04-06 | 2001-10-23 | Nicholas V. Perricone | Treatment of skin damage using olive oil polyphenols |
| US6277396B1 (en) * | 2000-05-11 | 2001-08-21 | Maximum Human Performance, Inc. | Dietary supplement containing a thermogenic substance and an adrenal support substance |
| JP2002080382A (ja) * | 2000-06-27 | 2002-03-19 | Kao Corp | アポトーシス抑制剤 |
| JP5060690B2 (ja) * | 2001-07-06 | 2012-10-31 | 丸善製薬株式会社 | サイクリックａｍｐホスホジエステラーゼ阻害剤 |
| US20030105027A1 (en) * | 2001-11-06 | 2003-06-05 | Rosenbloom Richard A. | Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
| JP4549625B2 (ja) * | 2002-01-05 | 2010-09-22 | 株式會社アモーレパシフィック | 人参サポニン代謝産物を有効成分とする微細乳化粒子及びその製造方法、並びにこれを含有する皮膚老化防止用の化粧料組成物 |
| KR100452165B1 (ko) * | 2002-01-29 | 2004-10-08 | 주식회사 태평양 | 리포펩티드계 보조 계면활성제를 이용한 나노에멀젼 및이를 함유하는 화장료 조성물 |
| CN1159005C (zh) * | 2002-02-06 | 2004-07-28 | 华东理工大学 | 抑制导致癌细胞转移的自由基复合物 |
| US7314634B2 (en) * | 2002-02-22 | 2008-01-01 | Steven Hernandez | Use of polyphenols to treat skin conditions |
| US20030162725A1 (en) * | 2002-02-25 | 2003-08-28 | Riker Donald K. | Synergistic pharmaceutical combinations for treating obesity with EGCG |
| KR20040009983A (ko) * | 2002-07-23 | 2004-01-31 | 아람 바이오시스템 주식회사 | 항산화 및/또는 항암 활성을 가진 화피 추출물 및 분획물 |
-
2004
- 2004-03-26 KR KR1020040020800A patent/KR100868905B1/ko not_active Expired - Lifetime
- 2004-06-01 JP JP2007504864A patent/JP4814870B2/ja not_active Expired - Lifetime
- 2004-06-01 EP EP04735693A patent/EP1727512B1/de not_active Expired - Lifetime
- 2004-06-01 CN CNB2004800425523A patent/CN100467010C/zh not_active Expired - Lifetime
- 2004-06-01 US US10/599,290 patent/US20080280838A1/en not_active Abandoned
- 2004-06-01 WO PCT/KR2004/001303 patent/WO2005092280A1/en not_active Ceased
- 2004-06-01 AT AT04735693T patent/ATE532498T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| KR100868905B1 (ko) | 2008-11-14 |
| CN1925834A (zh) | 2007-03-07 |
| CN100467010C (zh) | 2009-03-11 |
| JP2007530531A (ja) | 2007-11-01 |
| WO2005092280A1 (en) | 2005-10-06 |
| JP4814870B2 (ja) | 2011-11-16 |
| EP1727512A1 (de) | 2006-12-06 |
| EP1727512B1 (de) | 2011-11-09 |
| US20080280838A1 (en) | 2008-11-13 |
| EP1727512A4 (de) | 2009-05-06 |
| KR20050095415A (ko) | 2005-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121136T1 (el) | Φυτικα εκχυλισματα που περιεχουν κανναβινοειδη ως νευροπροστατευτικους παραγοντες | |
| CR10680A (es) | Composiciones de inhibidores de chk1 | |
| SV2010003673A (es) | Compuestos heterociclicos novedosos y usos de los mismos | |
| ATE554091T1 (de) | Aminotetrahydropyrane als dipeptidylpeptidase-iv- inhibitoren zur behandlung oder prävention von diabetes | |
| ECSP10010344A (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
| MX339402B (es) | Composiciones y metodos que comprenden variantes de serina proteasa. | |
| MX2011006254A (es) | Composiciones aclaradoras de la piel con inhibidores de acetilcolinesterasa. | |
| ATE408412T1 (de) | Verwendung von cannabidiol zur hemmung von gehirntumorzellmigration | |
| BRPI0906328A2 (pt) | "método para reduzir sulfeto de hidrogênio em asfalto, método para tratar asfalto e composição sequestrante de sulfeto de hidrogênio" | |
| ECSP109968A (es) | Depsipéptidos cíclicos | |
| CL2008000873A1 (es) | Compuestos derivados de pirrolidin amidas; composicion farmaceutica que comprende dichos compuestos; y su uso para tratar trombosis. | |
| ECSP10010273A (es) | Tratamiento de plantas de plátano y papa con una nueva composición antifúngica | |
| UA107325C2 (uk) | Спосіб обробки декоративних рослин | |
| EP2183084A4 (de) | Sägekette zum schneiden von aggregaten | |
| GT200800068A (es) | Tipo de brocoli que contiene inflorescencia con flósculos separados. | |
| MX2011006725A (es) | Combinacion de inhibidores de aurora cinasa y anticuerpos anti-cd20. | |
| EP2091530A4 (de) | Zusammensetzung zur hemmung von nadph-oxidaseaktivität | |
| ATE532814T1 (de) | Neue ammonium-polyurethan- und/oder polycarbonat- verbindungen | |
| ATE538799T1 (de) | Zusammensetzungen zur behandlung von haarverlust | |
| WO2010052312A3 (fr) | Médicament ou composition dermatologique comprenant un extrait peptidique d'avocat destiné au traitement et à la prévention du prurit | |
| DE602006014121D1 (de) | Sicheres druckverfahren zur verhinderung von produktfälschung | |
| ATE421870T1 (de) | 2-phenylethylbenzoat in kosmetischen öl-in-wasser-uv-lichtschutzemulsionen | |
| CL2009000665A1 (es) | Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas. | |
| ATE532498T1 (de) | Zusammensetzung mit ginsenosid f1 und egcg zur prävention von hautschäden | |
| BRPI0512063A (pt) | aperfeiçoamentos em composições depilatórias ou relacionados a composições depilatórias |